Based on weekly timeframe, ABBV at resistance of trend line.
NYSE:ABBV looking like a nice potential short coming soon if we reject the top of this wedge. Possible rejection down to the previous resistance turned support flip. Next level of course is the bottom of the wedge.
Order BUY ABBV NYSE Stop 145.78 LMT 145.78 will be automatically canceled at 20230401 01:00:00 EST ABBV daily bullish hammer beginning of wave 3 wave 5 uptrend that was ABC correction.
On ABBV as you see on the chart we have a buy idea.Thanks!
Hello dear Traders, Here is my idea for #ABBV Price closed above yellow line Target marked in the chart Invalidation level marked with red line IV30 % Rank: 2% Subdued Good luck! ❤️Please feel free to ask any question in comments. I will try to answer all! Thank you. Please, support my work with like, thank you!❤️
The PEAD projected a bullish outlook for $ABBV after a positive under reaction following its earnings release placing the stock in drift A with an expected accuracy of 63.64%.
ABBV has been in a down trend since the start of the year. With a break of the bear flag there is now only the long term trendline to save it.
AbbVie Inc. (ABBV) opened today much higher than the 1D MA200 (orange trend-line), which is a strong enough buy signal on its own. Coupled however with the fact that the rebound was achieved on the Higher Lows trend-line that started way back on the COVID (March 23 2020) market bottom, it makes it an even stronger one. In fact on a 2-3 month basis, this is the...
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in...
Hey traders, My weekly trade idea. The daily price is forming a textbook Cup&Handle formation. After the consolidation in the handle phase, the price is ready to go higher. The momentum will push the price and in my opinion, it is headed to test the all-time high in the 180$ area. The Relative Strength Index broke above its trend line and is moving upward to...
A textbook example of cup&handle pattern forming on ABBV, I think its interesting to dig deeper into the company, as its a defensive stock for just the conditions at the current moment.
Target 200 on 1.618 fib extension. Bottom indicator is correlation to SPY.
Healthcare has been a safe haven for big institutions, with oil hurting this may be a later breakdown following the market
AbbVie has been in this uptrend for multiple years, lets ride. LONG
What Happens when Bearish Harmonic Crabs and Cyphers Meet ?? Of all the major 11 S&P sub-sectors, the Health care (XLV) seems the most technically vunerable. (see insert) Herein we have a well formed Gartley pattern waiting to roll over. Drilling down to the major holdings of this index, AbbVie Inc. (ABBV) also looks the most vulnerable and ready to roll...
AbbVie - 30d expiry - We look to Sell a break of 132.58 (stop at 137.03) 133 continues to hold back the bears. 132.75 has been pivotal. Posted a Double Bottom formation. A break of the recent low at 132.74 should result in a further move lower. Our profit targets will be 121.01 and 117.01 Resistance: 154 / 157 / 160 Support: 147 / 142 / 137 Disclaimer –...
NYSE:ABBV AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid...